1-(2-(4-((4aS,8aR)-4-(3,4-Dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydrophthalazin-2(1H)-yl)piperidin-1-yl)-2-oxoethyl)pyrrolidine-2,5-dione

ID: ALA4566742

PubChem CID: 9827600

Max Phase: Preclinical

Molecular Formula: C27H32N4O6

Molecular Weight: 508.58

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccc(C2=NN(C3CCN(C(=O)CN4C(=O)CCC4=O)CC3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC

Standard InChI:  InChI=1S/C27H32N4O6/c1-36-21-8-7-17(15-22(21)37-2)26-19-5-3-4-6-20(19)27(35)31(28-26)18-11-13-29(14-12-18)25(34)16-30-23(32)9-10-24(30)33/h3-4,7-8,15,18-20H,5-6,9-14,16H2,1-2H3/t19-,20+/m0/s1

Standard InChI Key:  BLRZNXZBGGTDMQ-VQTJNVASSA-N

Molfile:  

 
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   30.5153  -17.9039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5142  -18.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2222  -19.1365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2204  -17.4991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9290  -17.9003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9298  -18.7193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6383  -19.1305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3466  -18.7155    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3419  -17.8934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6328  -17.4942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6400  -19.9477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.6279  -16.6821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3350  -16.2662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3311  -15.4498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6206  -15.0482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9128  -15.4609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9203  -16.2759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6152  -14.2311    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3202  -13.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0559  -19.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0548  -19.9392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7600  -20.3408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4685  -19.9371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4673  -19.1190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7576  -18.7046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1763  -20.3415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9241  -17.0867    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.9241  -19.5300    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.2062  -15.0617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2000  -14.2487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1800  -21.1587    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.8821  -19.9297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5917  -20.3351    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6809  -21.1464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4810  -21.3127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8865  -20.6031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3369  -19.9984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0762  -21.6961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.5027  -19.1982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  7 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 12  1  0
 15 18  1  0
 18 19  1  0
  8 20  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
  5 27  1  1
  6 28  1  1
 16 29  1  0
 29 30  1  0
 26 31  2  0
 26 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 33  1  0
 34 38  2  0
 37 39  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4566742

   1-(2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-1,2,4a,5,8,8a-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 508.58

Molecular Weight (Monoisotopic): 508.2322

AlogP: 1.97

#Rotatable Bonds: 6

Polar Surface Area: 108.82

Molecular Species: NEUTRAL

HBA: 7

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 1.00

CX LogP: 0.25

CX LogD: 0.25

Aromatic Rings: 1

Heavy Atoms: 37

QED Weighted: 0.43

Np Likeness Score: -0.76

References

1. Salado IG, Singh AK, Moreno-Cinos C, Sakaine G, Siderius M, Van der Veken P, Matheeussen A, van der Meer T, Sadek P, Gul S, Maes L, Sterk GJ, Leurs R, Brown D, Augustyns K..  (2020)  Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds.,  63  (7): [PMID:32196340] [10.1021/acs.jmedchem.9b00985]

Source

Source(1):

• Scientific Literature